HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levelsVelia Chiara Di Maio, F.P. Antonucci, Ada Bertoli et al.|Journal of Antimicrobial Chemotherapy|2015Cited by 13
In the ERA of New Direct Acting Antiviral Agents HCV Sequencing Allows the Most Accurate Subtype and Genotype AssignmentM. Aragri, Giustino Parruti, Velia Chiara Di Maio et al.|Journal of Hepatology|2016Cited by 1
Early viral dynamics in HCV-RNA decay and NS3-resistance development predict the risk of failure to first-generation protease inhibitorsValeria Cento, Francesca Ceccherini‐Silberstein, F.P. Antonucci et al.|Digestive and Liver Disease|2014Cited by 0
Clinical relevance of accurate HCV genotype and subtype assignment by NS3/NS5A/NS5B direct sequencing in the era of new direct acting antiviral agentsM. Aragri, A. Picciotto, Velia Chiara Di Maio et al.|Digestive and Liver Disease|2016Cited by 0